Cargando…
Recent Developments in ADC Technology: Preclinical Studies Signal Future Clinical Trends
The antibody–drug conjugate (ADC) field is in a transitional period. Older approaches to conjugate composition and dosing regimens still dominate the ADC clinical pipeline, but preclinical work is driving a rapid evolution in how we strategize to improve efficacy and reduce toxicity towards better t...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5696438/ https://www.ncbi.nlm.nih.gov/pubmed/29119409 http://dx.doi.org/10.1007/s40259-017-0254-1 |